These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 892949)

  • 21. Exposure of rats to inhalational anesthetics alters the hepatobiliary clearance of cholephilic xenobiotics.
    Watkins JB
    J Pharmacol Exp Ther; 1989 Aug; 250(2):421-7. PubMed ID: 2760837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of exenatide on the steady-state pharmacokinetics of digoxin.
    Kothare PA; Soon DK; Linnebjerg H; Park S; Chan C; Yeo A; Lim M; Mace KF; Wise SD
    J Clin Pharmacol; 2005 Sep; 45(9):1032-7. PubMed ID: 16100297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in beta acetyldigoxin resorption following administration of beta-sitosterine or cholestyramine].
    Schwartzkopff W; Jantke HJ
    Med Welt; 1980 Aug; 31(33):1183-8. PubMed ID: 7421554
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic voluntary exercise may alter hepatobiliary clearance of endogenous and exogenous chemicals in rats.
    Watkins JB; Crawford ST; Sanders RA
    Drug Metab Dispos; 1994; 22(4):537-43. PubMed ID: 7956727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of 14C-isotretinoin in healthy volunteers and volunteers with biliary T-tube drainage.
    Colburn WA; Vane FM; Bugge CJ; Carter DE; Bressler R; Ehmann CW
    Drug Metab Dispos; 1985; 13(3):327-32. PubMed ID: 2861992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimal biliary excretion and enterohepatic recirculation of lormetazepam in man as investigated by a new nasobiliary drainage technique.
    Hellstern A; Hildebrand M; Hümpel M; Hellenbrecht D; Saller R; Madetzki C
    Int J Clin Pharmacol Ther Toxicol; 1990 Jun; 28(6):256-61. PubMed ID: 1973917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered absorption of digoxin in patients given propantheline and metoclopramide.
    Thompson WG
    Lancet; 1973 Apr; 1(7806):783-4. PubMed ID: 4120773
    [No Abstract]   [Full Text] [Related]  

  • 28. Biliary elimination of aspirin after oral and intravenous administration in patients.
    Brune K; Nuernberg B; Schneider HT
    Agents Actions Suppl; 1993; 44():51-7. PubMed ID: 8372735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of digoxin and methyldigoxin in patients with acute hepatitis (author's transl)].
    Zilly W; Richter E; Rietbrock N
    Med Klin; 1978 Mar; 73(13):463-9. PubMed ID: 634206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of hypocholesterolemic interventions on digoxin bioavailability.
    Brown DD; Juhl RP; Warner SL
    Drug Metab Rev; 1979; 9(1):107-17. PubMed ID: 446263
    [No Abstract]   [Full Text] [Related]  

  • 31. Digoxin in hyperthyroidism.
    Huffman DH; Klaassen CD; Hartman CR
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):533-8. PubMed ID: 913019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.
    Hedman A; Angelin B; Arvidsson A; Dahlqvist R
    Eur J Clin Pharmacol; 1992; 42(5):481-5. PubMed ID: 1606994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cholestyramine and digoxin intoxication: therapeutic efficacy?].
    Frésard F; Balant L; Noble J; Garcia B; Muller AF
    Schweiz Med Wochenschr; 1979 Mar; 109(12):431-6. PubMed ID: 424712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excretion of chlordecone by the gastrointestinal tract: evidence for a nonbiliary mechanism.
    Boylan JJ; Cohn WJ; Egle JL; Blanke RV; Guzelian PS
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):579-85. PubMed ID: 86403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the pharmacokinetics of digoxin and dihydrodigoxin in cats in single-dose studies.
    Heinz N; Flasch H
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jun; 303(2):181-7. PubMed ID: 673023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability of digoxin and beta-methyl-digoxin.
    Padeletti L; Fantini F; Cinelli P; Gremigni C
    J Int Med Res; 1976; 4(5):352-4. PubMed ID: 1028636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of nonlinearity in digoxin pharmacokinetics.
    Wagner JG; Popat KD; Das SK; Sakmar E; Movahhed H
    J Pharmacokinet Biopharm; 1981 Apr; 9(2):147-66. PubMed ID: 7277206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of effect of cholestyramine on the pharmacokinetics of clofibrate in man.
    Sedaghat A; Ahrens EH
    Eur J Clin Invest; 1975 Apr; 5(2):177-85. PubMed ID: 1149779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pretreatment with spironolactone of pharmacokinetics of 4'''-methyldigoxin in man.
    Abshagen U; Rennekamp H; Kuhlmann J
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):87-92. PubMed ID: 934358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary excretion of reduced metabolites of digoxin.
    Lindenbaum J; Tse-Eng D; Butler VP; Rund DG
    Am J Med; 1981 Jul; 71(1):67-74. PubMed ID: 7246583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.